ERDERA contributed to the first Journée nationale FrBioNet, bringing a European rare disease perspective to discussions with the French biobanking community.

ERDERA connects rare disease research and biobanking at FrBioNet’s first national event

Journée nationale FrBioNet

On 24 September 2026, Dr Başak Uysal, Data Service Hub Project Manager at the ERDERA Coordination Office, presented ERDERA at the first Journée nationale FrBioNet, held at Hôpital Bicêtre AP-HP near Paris.

In a pre-recorded presentation entitled“ERDERA: Connecting Rare Disease Research, Data and Biobanking Across Europe”, Dr Uysal introduced ERDERA’s work to connect research funding, clinical studies, data infrastructures and patient-centred innovation across Europe.

The presentation highlighted the importance of harmonisation, FAIR data practices and interoperability. It also explored connections between rare disease research and biobanking, including the role of high-quality metadata, data standardisation and links between biological samples and clinical and genomic data.

ERDERA’s participation provided an opportunity to engage with the French biobanking community and consider how cooperation between national and European infrastructures can support research on rare diseases.

Find out more about the Journée nationale FrBioNet.

 

Photo by FrBioNet Linkedin.

News & Updates

You might also be interested in

November 2 @ 1:00 pm - 2:00 pm
ERDERA Ethics & Regulatory Webinar Series
Ana Rath, Data Services Co-Lead in ERDERA, explains how the consortium is helping researchers and data holders make rare disease data more findable, interoperable and reusable while protecting privacy and keeping data holders in control.
November 25 - November 26
Discover practical pathways to repurpose medicines for rare diseases, exchange experiences and best practices between underrepresented and high-performing countries, and build new partnerships at the ERDERA Knowledge Exchange Meeting in Riga on 25-26 November.
ERDERA will return to the World Orphan Drug Congress Europe with a booth and an interactive pre-conference workshop examining where artificial intelligence can support rare disease research and therapeutic development, and where human expertise remains essential.